Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials-Reference-Cited by-同舟云学术

Maintenance based Bevacizumab versus complete stop or continuous therapy after induction therapy in first line treatment of stage IV colorectal cancer: A meta-analysis of randomized clinical trials

Published:2016-08 Issue: Volume:104 Page:115-123
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Tamburini Emiliano,Rudnas Britt,Santelmo Carlotta,Drudi Fabrizio,Gianni Lorenzo,Nicoletti Stefania V.L.,Ridolfi Claudio,Tassinari Davide

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference36 articles.

1. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase III MRC COIN trial;Adams;Lancet Oncol.,2011

2. Continuous versus intermittent chemotherapy in metastatic colorectal cancer;Alexopoulos;J. Clin. Oncol.,2006

3. Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study;Andre;Ann. Oncol.,2007

4. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML 18147): a randomised phase 3 trial;Bennouna;Lancet Oncol.,2013

5. Health literacy screening prior to education for patients with cancer.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review;Current Oncology Reports;2023-02-13

2. MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAF metastatic colorectal cancer;ESMO Open;2022-10

3. Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer;BMC Medical Research Methodology;2021-01-09

4. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy;Clinical and Translational Oncology;2020-01-02

5. Panitumumab‐based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials;International Journal of Cancer;2019-01-24